As of June 10, 2026, Nuvectis Pharma's top three insider holders are Ron Bentsur (Chairman Ceo, 3.68Mn shares), Marlio Charles Mosseri (TenPercentOwner, 3.14Mn shares), Ron Bentsur (Chairman Ceo, 2.83Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Ron Bentsur | Chairman Ceo | 3,675,924 | 0 | 09 Jan, 2026 |
| James F Iii Oliviero | - | 87,828 | 0 | 12 Jun, 2025 |
| Kenneth Hoberman | - | 133,140 | 0 | 12 Jun, 2025 |
| Marlio Charles Mosseri | - | 0 | 3,136,576 | 29 Oct, 2025 |
| Matthew L. Kaplan | - | 124,760 | 0 | 06 Nov, 2025 |
| Shay Shemesh | Chief Dev. Ops. Officer | 1,793,068 | 0 | 09 Jan, 2026 |
| Michael J. Carson | Vice President, Finance | 200,118 | 0 | 09 Jan, 2026 |
| Enrique Poradosu | Chief Science Business Off | 1,806,319 | 0 | 09 Jan, 2026 |
| Juan Sanchez | - | 78,150 | 0 | 06 Nov, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 06 Jan, 2026 | Enrique Poradosu | Common Stock | A | 150,000 | $0.00 | 1,806,319 | D | A |
| 06 Jan, 2026 | Shay Shemesh | Common Stock | A | 150,000 | $0.00 | 1,793,068 | D | A |
| 06 Jan, 2026 | Shay Shemesh | Common Stock | A | 150,000 | $0.00 | 1,793,068 | D | A |
| 06 Jan, 2026 | Ron Bentsur | Common Stock | A | 150,000 | $0.00 | 3,675,924 | D | A |
| 06 Jan, 2026 | Enrique Poradosu | Common Stock | A | 150,000 | $0.00 | 1,806,319 | D | A |
| 06 Jan, 2026 | Michael J. Carson | Common Stock | A | 61,200 | $0.00 | 200,118 | D | A |
| 05 Nov, 2025 | Matthew L. Kaplan | Common Stock | A | 11,000 | $5.84 | 124,760 | D | P |
| 05 Nov, 2025 | Juan Sanchez | Common Stock | A | 13,000 | $5.79 | 78,150 | D | P |
| 05 Nov, 2025 | Juan Sanchez | Common Stock | A | 13,000 | $5.79 | 78,150 | D | P |
| 05 Nov, 2025 | Ron Bentsur | Common Stock | A | 5,000 | $5.72 | 3,525,924 | D | P |
| 22 Sep, 2025 | Juan Sanchez | Common Stock | A | 30,000 | $0.00 | 65,150 | D | A |
| 22 Sep, 2025 | Juan Sanchez | Common Stock | A | 30,000 | $0.00 | 65,150 | D | A |
| 23 Oct, 2025 | Marlio Charles Mosseri | Common Stock | A | 46,900 | $6.06 | 3,028,706 | I | P |
| 24 Oct, 2025 | Marlio Charles Mosseri | Common Stock | A | 35,034 | $6.15 | 3,063,740 | I | P |
| 27 Oct, 2025 | Marlio Charles Mosseri | Common Stock | A | 72,836 | $6.28 | 3,136,576 | I | P |
| 20 Jun, 2025 | Marlio Charles Mosseri | Common Stock | A | 5,603 | $7.99 | 2,981,806 | I | P |
| 17 Jun, 2025 | Marlio Charles Mosseri | Common Stock | A | 5,399 | $8.11 | 2,948,160 | I | P |
| 18 Jun, 2025 | Marlio Charles Mosseri | Common Stock | A | 28,043 | $8.05 | 2,976,203 | I | P |
| 12 Jun, 2025 | James F Iii Oliviero | Common Stock | A | 30,000 | $0.00 | 87,828 | D | A |
| 12 Jun, 2025 | Matthew L. Kaplan | Common Stock | A | 30,000 | $0.00 | 113,760 | D | A |